Medical Device Risk Classification A–D: Market Entry in Southeast Asia

How ASEAN regulators assign risk classes to medical devices, why it determines your distributor requirements, and what each class means for registration timelines across Indonesia, Malaysia, Singapore, Thailand, Vietnam, and the Philippines.

The ASEAN AMDD Framework

The ASEAN Medical Device Directive (AMDD)established a harmonised four-class risk-based framework for medical devices across Southeast Asia. While implementation varies by country, Indonesia, Malaysia, Singapore, Thailand, Vietnam, and the Philippines all apply this same A/B/C/D classification logic — making it the single most important reference point for SEA market entry planning.

The Four Risk Classes Explained

Class A — Low Risk

Lowest Risk · Simplest Pathway. Non-invasive devices with minimal risk to the patient. Regulatory pathway is the most streamlined, with self-declaration or simplified submission accepted in most SEA markets.

Examples: Bandages, hospital furniture, tongue depressors, patient lifts, manual wheelchairs, examination gloves (non-sterile).

Class B — Low-Moderate Risk

Moderate Risk · Standard Documentation. Devices that interact with the body but pose limited risk. Require a full registration dossier including GMP certificates, Declaration of Conformity, and clinical evidence summary.

Examples: Blood glucose monitors, contact lenses, wound dressings (sterile), ultrasonic physiotherapy devices, rapid diagnostic tests.

Class C — Moderate-High Risk

High Risk · Extended Technical Review. Active implantable or life-sustaining devices. Require specialised distributor capabilities, longer registration review timelines, and often a local clinical data requirement.

Examples: Ventilators, dialysis equipment, infusion pumps, haemofiltration machines, defibrillators, anaesthesia machines.

Class D — High Risk

Highest Risk · Most Complex Pathway.Implantables and devices in direct contact with the central cardiovascular system or CNS. The most stringent pathway — requires fully specialised distributors with dedicated surgical teams and KOL relationships.

Examples: Cardiac stents, joint implants, cochlear implants, spinal fixation systems, neurosurgical devices, heart valves.

Registration Requirements by Risk Class (Indonesia)

Distributor Requirements by Risk Class

Risk class doesn't just affect your registration application — it directly determines what kind of distributor you need. Higher class devices require distributors with specialist capabilities that are genuinely scarce across Indonesia's 7,100+ IDAK holders and across SEA's combined 13,000+ licensed distributors.

SEA Market Comparison: Risk Class Landscape

Frequently Asked Questions

What is the ASEAN AMDD framework and which countries follow it?

The ASEAN Medical Device Directive (AMDD) is a harmonised regulatory framework developed by ASEAN member states to align medical device classification and registration standards across the region. It defines four risk classes (A through D) based on intended use, duration of contact, invasiveness, and potential harm.

Among the six major SEA markets, Malaysia, Singapore, Thailand, Vietnam, and the Philippines have formally adopted AMDD-aligned classification systems. Indonesia's Kemenkes uses a broadly similar four-class system but has applied it through its own regulatory instruments (Permenkes) rather than formally adopting the AMDD text. In practice, a Class B device in Malaysia will typically be classified as Class B (or equivalent) across the other AMDD-aligned markets.

What types of medical devices are classified as Class D in Southeast Asia?

Class Dis the highest-risk category under the AMDD framework — reserved for devices where failure could directly cause death or serious irreversible injury. Common Class D examples include: active implantable devices (pacemakers, cochlear implants, neurostimulators), cardiovascular implants (heart valves, coronary stents), total joint replacements, and long-term implantable drug-delivery systems.

In Indonesia, Class D devices require the most comprehensive NIE documentation, including full clinical data, and are subject to the longest registration timelines (often 12–24 months). Distributors handling Class D products must demonstrate enhanced regulatory and technical capabilities.

How does risk classification affect which distributor I should choose?

Risk class is one of the most important filters when selecting a distributor, because higher-risk devices require more regulatory expertise from the distributor. Class C and D distributors need dedicated regulatory affairs staff, experience managing clinical data submissions, and relationships with in-country regulatory reviewers.

Beyond regulatory capability, Class D distributors often need hospital-direct sales infrastructure and biomedical engineering support — very different from a Class A/B distributor who may primarily serve pharmacies or general medical supply chains. MedMatchAi lets you filter distributors by the risk classes of devices they have previously registered, helping you identify truly qualified partners.

Can the same device have different risk classifications in different SEA markets?

Yes — and this is one of the most common surprises for manufacturers entering multiple SEA markets simultaneously. While the AMDD framework harmonises the classification rules in principle, national regulators apply their own interpretations and classification guidelines. The same device can be Class B in one country and Class C in another, depending on how the local regulator interprets the intended use and the classification criteria.

Differences frequently occur for combination products, devices with software components, and devices with multiple intended uses. Always confirm classification with each country's regulator or a local regulatory consultant before assuming your home-market classification applies regionally.

What is the difference between Class C and Class D registration requirements?

Both Class C and Class D devices require full technical documentation, but Class D adds mandatory clinical evidence requirements that Class C can sometimes satisfy with literature-based clinical evaluation. For Class D devices, most SEA regulators require clinical investigation data (human trials) or substantial clinical equivalence data from a predicate device.

Additionally, Class D registration often involves a more formal review committee process, longer official review timelines (statutory periods are typically 90–180 days for Class D vs. 60–90 days for Class C), and more rigorous post-market surveillance obligations. The distributor's regulatory team must be equipped to handle these extended engagements with national health authorities.

For a deeper look at Indonesia's specific registration mechanics, see our guides on IDAK, NIE & IPAK explained and how to find a distributor in Indonesia.